ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

WOK vs NVNO // ENTERPRISE SCALE & MARKET CAP

WORK Medical Technology Group LTD (Class A) (NASDAQ) VS. enVVeno Medical Corporation (NASDAQ) • 15-METRIC TALLY: WOK 2 — NVNO 1
▲ ENTERPRISE SCALE & MARKET CAP LEADER: WOK
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (WOK VS. NVNO) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC WOK NVNO SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) — -35.00% — TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin — — — TIE /operating-margins <GO>
Net Profit Margin — — — TIE /net-margins <GO>
Revenue Growth (YoY) — — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 4/9 3/9 +1.00 WOK /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 34.8 39.8 -5.00 NVNO /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap ACTIVE $4.9M $4.9M $36.7K WOK /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR WOK REV NVNO REV WOK GROSS % NVNO GROSS % WOK FCF NVNO FCF
FY 2025 $0 $0 — — $4.9M -$15.6M
FY 2024 $0 $0 — — -$11.5M -$16.9M
FY 2023 $0 $0 — — $2.2M -$18.9M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
WOK // BETA —
NVNO // BETA —